Bill has been with FSI since 2008 and leads client engagements focusing on growth strategy assignments for companies and investors in the biopharma, life science tools/diagnostics and Medtech sectors. Bill also leads FSI’s strategic partnering advisory practice and was active with Fletcher Spaght Ventures sourcing deals and conducting due diligence.
Prior to FSI, Bill was as a strategy consultant in the life sciences practice of Wood Mackenzie and in business development roles at Acusphere, Inc., a diagnostics/drug delivery company.
He holds the FINRA Series 79, 82, and 63 securities licenses.
MBA, Boston University Questrom School of Business
MS, Biotechnology, University of Pennsylvania
BA, Biology, Skidmore College
Time with his wife and two children